FGEN
Price
$12.31
Change
+$0.07 (+0.57%)
Updated
Sep 26 closing price
Capitalization
49.78M
IMNM
Price
$11.59
Change
+$1.44 (+14.19%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
883.94M
52 days until earnings call
Interact to see
Advertisement

FGEN vs IMNM

Header iconFGEN vs IMNM Comparison
Open Charts FGEN vs IMNMBanner chart's image
FibroGen
Price$12.31
Change+$0.07 (+0.57%)
Volume$15.46K
Capitalization49.78M
Immunome
Price$11.59
Change+$1.44 (+14.19%)
Volume$31.14K
Capitalization883.94M
FGEN vs IMNM Comparison Chart in %
Loading...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FGEN vs. IMNM commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGEN is a Buy and IMNM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (FGEN: $12.30 vs. IMNM: $11.59)
Brand notoriety: FGEN and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FGEN: 18% vs. IMNM: 95%
Market capitalization -- FGEN: $49.52M vs. IMNM: $883.94M
FGEN [@Biotechnology] is valued at $49.52M. IMNM’s [@Biotechnology] market capitalization is $883.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FGEN’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • FGEN’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, both FGEN and IMNM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FGEN’s TA Score shows that 3 TA indicator(s) are bullish while IMNM’s TA Score has 5 bullish TA indicator(s).

  • FGEN’s TA Score: 3 bullish, 5 bearish.
  • IMNM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than FGEN.

Price Growth

FGEN (@Biotechnology) experienced а +8.75% price change this week, while IMNM (@Biotechnology) price change was +23.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

IMNM is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($884M) has a higher market cap than FGEN($49.8M). IMNM YTD gains are higher at: -4.379 vs. FGEN (-7.007). FGEN has higher annual earnings (EBITDA): -77.3M vs. IMNM (-187.92M). IMNM has more cash in the bank: 268M vs. FGEN (23.4M). IMNM has less debt than FGEN: IMNM (4.14M) vs FGEN (73.7M). IMNM has higher revenues than FGEN: IMNM (12.6M) vs FGEN (7.35M).
FGENIMNMFGEN / IMNM
Capitalization49.8M884M6%
EBITDA-77.3M-187.92M41%
Gain YTD-7.007-4.379160%
P/E RatioN/AN/A-
Revenue7.35M12.6M58%
Total Cash23.4M268M9%
Total Debt73.7M4.14M1,779%
FUNDAMENTALS RATINGS
FGEN: Fundamental Ratings
FGEN
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
45
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FGENIMNM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MALVX31.99N/A
N/A
BlackRock Advantage Large Cap Val Instl
PJECX15.15N/A
N/A
PGIM US Real Estate C
FSEBX14.49N/A
N/A
Fidelity Sustainable U.S. Equity Fund
JNGIX79.94-0.45
-0.56%
Janus Henderson Growth And Income D
BIECX25.98-0.26
-0.99%
Brandes International Equity C

FGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, FGEN has been loosely correlated with AVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if FGEN jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGEN
1D Price
Change %
FGEN100%
+0.53%
AVTX - FGEN
57%
Loosely correlated
-6.49%
JAGX - FGEN
33%
Loosely correlated
+4.88%
ZBIO - FGEN
32%
Poorly correlated
+7.89%
IMNM - FGEN
32%
Poorly correlated
+14.13%
COGT - FGEN
31%
Poorly correlated
+6.55%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-9.33%
IDYA - IMNM
59%
Loosely correlated
+0.08%
SYRE - IMNM
54%
Loosely correlated
-8.18%
BEAM - IMNM
53%
Loosely correlated
-2.12%
IPSC - IMNM
53%
Loosely correlated
+0.66%
IMVT - IMNM
53%
Loosely correlated
+1.36%
More